Learn more about the data

Results

Arthrosamid® is a permanent injectable hydrogel that delivers long-lasting, proven pain relief without surgery — redefining treatment for knee OA.

Adobe Stock 271209515

Vector 382

Pain Reduction

In all our studies , Arthrosamid® exceeds the MCID of 9 points 16 and improvement is maintained up to 3 years after a single injection.

Group 6

Close to 80% Response rate

Patients in the under 70 years group reported close to 80% positive response rate following treatment with Arthrosamid®.

Heart

Safe & Effective

Arthrosamid® remains safe and effective for its intended use 3 years after treatment.

Reproducible pain reduction Results

In all our studies , Arthrosamid® exceeds the MCID of 9 points 16 and improvement is maintained up to 3 years after a single injection.

Grouped studies

WOMAC pain subscale change from baseline across studies

Responder rates by age

Patients in the under 70 years group reported close to 80% positive response rate following treatment with Arthrosamid®.

Simple response rate

Safety of intra-articular polyacrylamide hydrogel (iPAAG) for the treatment of knee osteoarthritis symptoms

16% of the participants had received arthroplasty surgery for knee OA of the treated knee.

There were no unexpected descriptions of abnormalities that could be associated with the prior treatment with iPAAG in the surgical reports.

“Of these patients, none reported dissatisfaction with the outcome of the surgery and the arthroplasties were well functioning.”

iPAAG: injectable polyacrylamide hydrogel

Indication, Patient Group and Usage

Arthrosamid® is intended to be used for symptomatic treatment of adult patients with knee osteoarthritis.

Treatment with Arthrosamid® may not be suitable for everyone. Your doctor is the best person to advise you.

We use cookies to give you the best online experience. By agreeing, you accept the use of cookies in accordance with our cookie policy.